Global and United States Prostate Cancer Screening Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Prostate Cancer Screening Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Physical Exam
  • 1.2.3 Laboratory Tests
  • 1.2.4 Imaging Tests
  • 1.2.5 Gleason Score
  • 1.2.6 TNM Score
  • 1.2.7 Genetic Tests
  • 1.2.8 Digital Rectal Exam
  • 1.2.9 Biopsy
• 1.3 Market by Application
  • 1.3.1 Global Prostate Cancer Screening Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Research Labs
  • 1.3.5 Cancer Institutes
  • 1.3.6 Diagnostic Centers
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Prostate Cancer Screening Market Perspective (2015-2026)
• 2.2 Global Prostate Cancer Screening Growth Trends by Regions
  • 2.2.1 Prostate Cancer Screening Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prostate Cancer Screening Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prostate Cancer Screening Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate Cancer Screening Players by Market Size
  • 3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2015-2020)
  • 3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2015-2020)
• 3.2 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Prostate Cancer Screening Revenue
• 3.4 Global Prostate Cancer Screening Market Concentration Ratio
  • 3.4.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2019
• 3.5 Key Players Prostate Cancer Screening Area Served
• 3.6 Key Players Prostate Cancer Screening Product Solution and Service
• 3.7 Date of Enter into Prostate Cancer Screening Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Screening Breakdown Data by Type (2015-2026)

• 4.1 Global Prostate Cancer Screening Historic Market Size by Type (2015-2020)
• 4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2021-2026)

5 Prostate Cancer Screening Breakdown Data by Application (2015-2026)

• 5.1 Global Prostate Cancer Screening Historic Market Size by Application (2015-2020)
• 5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prostate Cancer Screening Market Size (2015-2026)
• 6.2 North America Prostate Cancer Screening Market Size by Type (2015-2020)
• 6.3 North America Prostate Cancer Screening Market Size by Application (2015-2020)
• 6.4 North America Prostate Cancer Screening Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Prostate Cancer Screening Market Size (2015-2026)
• 7.2 Europe Prostate Cancer Screening Market Size by Type (2015-2020)
• 7.3 Europe Prostate Cancer Screening Market Size by Application (2015-2020)
• 7.4 Europe Prostate Cancer Screening Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Prostate Cancer Screening Market Size (2015-2026)
• 8.2 China Prostate Cancer Screening Market Size by Type (2015-2020)
• 8.3 China Prostate Cancer Screening Market Size by Application (2015-2020)
• 8.4 China Prostate Cancer Screening Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Prostate Cancer Screening Market Size (2015-2026)
• 9.2 Japan Prostate Cancer Screening Market Size by Type (2015-2020)
• 9.3 Japan Prostate Cancer Screening Market Size by Application (2015-2020)
• 9.4 Japan Prostate Cancer Screening Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Prostate Cancer Screening Market Size (2015-2026)
• 10.2 Southeast Asia Prostate Cancer Screening Market Size by Type (2015-2020)
• 10.3 Southeast Asia Prostate Cancer Screening Market Size by Application (2015-2020)
• 10.4 Southeast Asia Prostate Cancer Screening Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Prostate Cancer Screening Introduction
  • 11.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2015-2020))
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 Almac
  • 11.2.1 Almac Company Details
  • 11.2.2 Almac Business Overview
  • 11.2.3 Almac Prostate Cancer Screening Introduction
  • 11.2.4 Almac Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.2.5 Almac Recent Development
• 11.3 Bayer
  • 11.3.1 Bayer Company Details
  • 11.3.2 Bayer Business Overview
  • 11.3.3 Bayer Prostate Cancer Screening Introduction
  • 11.3.4 Bayer Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.3.5 Bayer Recent Development
• 11.4 Beckman Coulter
  • 11.4.1 Beckman Coulter Company Details
  • 11.4.2 Beckman Coulter Business Overview
  • 11.4.3 Beckman Coulter Prostate Cancer Screening Introduction
  • 11.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.4.5 Beckman Coulter Recent Development
• 11.5 BioméRieux
  • 11.5.1 BioméRieux Company Details
  • 11.5.2 BioméRieux Business Overview
  • 11.5.3 BioméRieux Prostate Cancer Screening Introduction
  • 11.5.4 BioméRieux Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.5.5 BioméRieux Recent Development
• 11.6 Genomic Health
  • 11.6.1 Genomic Health Company Details
  • 11.6.2 Genomic Health Business Overview
  • 11.6.3 Genomic Health Prostate Cancer Screening Introduction
  • 11.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.6.5 Genomic Health Recent Development
• 11.7 Mayo Clinic
  • 11.7.1 Mayo Clinic Company Details
  • 11.7.2 Mayo Clinic Business Overview
  • 11.7.3 Mayo Clinic Prostate Cancer Screening Introduction
  • 11.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.7.5 Mayo Clinic Recent Development
• 11.8 Mdxhealth
  • 11.8.1 Mdxhealth Company Details
  • 11.8.2 Mdxhealth Business Overview
  • 11.8.3 Mdxhealth Prostate Cancer Screening Introduction
  • 11.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.8.5 Mdxhealth Recent Development
• 11.9 Roche Diagnostics
  • 11.9.1 Roche Diagnostics Company Details
  • 11.9.2 Roche Diagnostics Business Overview
  • 11.9.3 Roche Diagnostics Prostate Cancer Screening Introduction
  • 11.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.9.5 Roche Diagnostics Recent Development
• 11.10 Rosetta Genomics
  • 11.10.1 Rosetta Genomics Company Details
  • 11.10.2 Rosetta Genomics Business Overview
  • 11.10.3 Rosetta Genomics Prostate Cancer Screening Introduction
  • 11.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2015-2020)
  • 11.10.5 Rosetta Genomics Recent Development
• 11.11 Thermo Fisher Scientific
  • 10.11.1 Thermo Fisher Scientific Company Details
  • 10.11.2 Thermo Fisher Scientific Business Overview
  • 10.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction
  • 10.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2015-2020)
  • 10.11.5 Thermo Fisher Scientific Recent Development
• 11.12 Hologic
  • 10.12.1 Hologic Company Details
  • 10.12.2 Hologic Business Overview
  • 10.12.3 Hologic Prostate Cancer Screening Introduction
  • 10.12.4 Hologic Revenue in Prostate Cancer Screening Business (2015-2020)
  • 10.12.5 Hologic Recent Development
• 11.13 Myriad Genetics
  • 10.13.1 Myriad Genetics Company Details
  • 10.13.2 Myriad Genetics Business Overview
  • 10.13.3 Myriad Genetics Prostate Cancer Screening Introduction
  • 10.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2015-2020)
  • 10.13.5 Myriad Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer